8-K: Profusa, Inc. Issues Convertible Note to Ascent Partners Fund

Profusa, Inc. has entered into a material definitive agreement by issuing a Senior Secured Convertible Promissory Note to Ascent Partners Fund LLC.

Summary

• Profusa, Inc. issued a Senior Secured Convertible Promissory Note to Ascent Partners Fund LLC on October 15, 2026.
• The note has a principal amount of $769,230.77 and was purchased for $700,000.00, indicating an original issue discount.
• The note matures on October 15, 2027, or the Option Closing Date, whichever comes first.
• Interest accrues at 7% annually, increasing to 18% upon an Event of Default.
• The note is convertible into shares of Common Stock at a conversion price of $4.28 per share, subject to adjustments and a floor price of $1.07.
• Monthly amortization payments are due starting January 1, 2027, which can be paid in shares of Common Stock under certain conditions.
• A mandatory prepayment of 33% of net proceeds from any Subsequent Offering is required.
• The note is secured by a Security Agreement and Intellectual Property Security Agreement.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative development due to the issuance of a convertible note with potentially dilutive terms and significant covenants, indicating potential financial strain.

Positives

• Secured funding through a convertible note, providing capital for operations or strategic initiatives.
• The note allows for interest and amortization payments to be made in shares of Common Stock, potentially preserving cash.
• The conversion price is fixed at $4.28, providing some predictability for future equity dilution.

Negatives

• The issuance of a convertible note with a significant original issue discount ($69,230.77) suggests a distressed financing situation.
• The note is secured, indicating increased risk for the company if default occurs.
• Covenants restrict the company from incurring additional debt, selling assets, or making restricted payments while the note principal exceeds $200,000.
• Potential for significant dilution to existing shareholders upon conversion, especially if the stock price is below the conversion price.
• A 5% Cash Payment Fee is applied to voluntary prepayments, discouraging early repayment in cash.
• An 18% Default Rate on interest and a 10% Late Fee indicate severe penalties for non-compliance.

Risks

• The company may face financial distress leading to an Event of Default, triggering accelerated repayment and potential loss of assets due to the security interest.
• Significant dilution to existing shareholders if the note is converted, particularly if the stock price remains below the conversion price.
• Restrictions imposed by negative covenants could hinder the company's operational flexibility and strategic decision-making.
• The company's ability to meet monthly amortization payments, especially if required to be made in cash, could be a challenge.
• The 'penny stock' status or delisting from the Principal Trading Market constitutes an Event of Default.
• Failure to meet public information requirements under Rule 144 can also lead to an Event of Default.

Future Outlook

The filing primarily details a financing agreement and does not contain specific forward-looking financial guidance. However, it notes that forward-looking statements may be present regarding the note, potential conversions, and share issuance, subject to risks and uncertainties.

Management Comments

• The filing does not contain direct quotes from management regarding this specific transaction.

Industry Context

StockSavvy.ai notes that the issuance of secured convertible debt, especially with an original issue discount, is often indicative of companies facing capital constraints or seeking flexible financing options. This is common in early-stage or growth-phase companies, but the secured nature and restrictive covenants suggest a more challenging financial position for Profusa, Inc.

Comparison to Industry Standards

• The terms of this convertible note, including the interest rate, conversion price, and floor price, should be compared against similar debt instruments issued by companies in the biotechnology or medical device sector. However, specific comparable companies and their terms are not provided in this filing.
• The negative covenants restricting debt, asset sales, and restricted payments are standard for secured debt but their stringency should be evaluated against industry norms for companies of similar size and financial health.

Stakeholder Impact

• Shareholders: Potential for significant dilution if the convertible note is converted, especially if the stock price is below the conversion price. The secured nature of the debt also increases risk.
• Creditors: The negative covenants restrict the company's ability to incur additional debt, which could impact future lending opportunities.
• Management: Subject to covenants that limit strategic and financial flexibility.

Next Steps

• The company must make monthly amortization payments starting January 1, 2027, which can be paid in cash or shares.
• The company must prepay 33% of net proceeds from any Subsequent Offering.
• Ascent Partners Fund LLC can convert the note into common stock at $4.28 per share, subject to limitations.
• The company is subject to negative covenants as long as the outstanding principal exceeds $200,000.

Key Dates

Recommendation

The issuance of a secured convertible note with an original issue discount and restrictive covenants suggests potential financial challenges. While it provides immediate capital, the terms indicate a higher risk profile and potential for significant future dilution. A 'hold' recommendation is appropriate pending further clarity on the company's operational performance and ability to manage its debt obligations and avoid dilution.

Keywords

Convertible Note, Secured Debt, Financing, Dilution, Ascent Partners Fund, Profusa, Inc., Material Definitive Agreement, Amortization